Medline Inc.: Beware The Private Equity Overhang
Medline Inc. faces pressure from private equity overhang and a recent downward revision in FY26 adj. EBITDA guidance. I rate ...
Model output · Signal date 2026-10-16
Medline Inc. (MDLN) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Rating · 90D
Total
90-day forecast
Sign up free to reveal
30-day forecast
Total
Rank in coverage
Middle 30%
of 5184 stocks scored
Rank correlation · 90D
33.0%
Spearman, 103 dates
Market Cap
$47.28B
large-cap · #5 of 60 peers
Summary
Medline Inc. (MDLN) stock forecast summary
On Oct. 16, 2026, MDLN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5184 stocks scored that day.
Medline Inc. is a large-cap company with a market capitalization of $47.28B. It ranks number 5 by market capitalization among the 60 Surgical & Medical Instruments & Apparatus issuers in our coverage with a current forecast.
For MDLN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 103 forecast dates between 2026-02-25 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 31.0%, measured on 146 forecast dates between 2026-02-25 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MDLN included.
Follow MDLN freePrice
MDLN price chart and AI forecast
Cross-section · 2026-10-16
How MDLN ranks among 5184 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-06-27
Medline Inc. (MDLN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Surgical & Medical Instruments & Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | MDLN | Rank |
|---|---|---|
| Market Cap | $47.28B | 5/60 |
| P/B Ratio | 4.09x | 31/55 |
| Book Value/Share | $8.80 | – |
Financial Health
| Metric | MDLN | Rank |
|---|---|---|
| Current Ratio | 4.33x | 26/59 |
| Quick Ratio | 2.61x | 27/55 |
| D/E Ratio | 1.75x | 12/56 |
| Financial Leverage | 3.40x | 8/54 |
| Interest Coverage | 1.5x | 20/48 |
| Working Capital | $9.03B | 1/59 |
Dividend & Shareholder Information
| Metric | MDLN | Rank |
|---|---|---|
| Shares Outstanding | 1315M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $11.74B | 29.8% of assets |
| Cash & Short-term Investments | $2.33B | 5.9% of assets |
| Accounts Receivable | $3.66B | 9.3% of assets |
| Inventory | $4.67B | 11.9% of assets |
| Total Liabilities | $20.27B | 51.5% of assets |
| Short-term Debt | $1.67B | 4.2% of assets |
Quarterly Financial Reports
MDLN quarterly financials and insider trading
Industry Peers · Surgical & Medical Instruments & Apparatus
Medline Inc. (MDLN) industry peers
Companies classified under the same SEC industry code as Medline Inc. (Surgical & Medical Instruments & Apparatus): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| MDLN Medline Inc. | ▶ | $47.28B |
| SYK Stryker Corp | ▼ | $113.02B |
| MMM 3m Co | ▶ | $84.97B |
| BSX Boston Scientific Corp | ▼ | $64.33B |
| BDX Becton Dickinson & Co | ▼ | $52.23B |
| RMD Resmed Inc | ▼ | $34.47B |
| DXCM Dexcom Inc | ▼ | $32.47B |
| WST West Pharmaceutical Services Inc | ▼ | $27.03B |
| SOLV Solventum Corp | ▼ | $14.61B |
| BAX Baxter International Inc | ▶ | $13.07B |
| PEN Penumbra Inc | ▼ | $12.64B |
| GMED Globus Medical Inc | ▼ | $10.30B |
| PODD Insulet Corp | ▼ | $9.79B |
| GKOS Glaukos Corp | ▲ | $9.72B |
| TFX Teleflex Inc | ▼ | $5.53B |
| HAE Haemonetics Corp | ▼ | $5.38B |
| MMSI Merit Medical Systems Inc | ▼ | $5.33B |
| STVN Stevanato Group S.P.A. | ▲ | $5.16B |
| MMED Minimed Group, Inc. | ▶ | $4.92B |
| HTFL Heartflow, Inc. | ▲ | $4.20B |
| ICUI Icu Medical Inc/De | ▼ | $4.08B |
| IRTC Irhythm Holdings, Inc. | ▼ | $3.58B |
| PLSE Pulse Biosciences, Inc. | ▲ | $3.17B |
| ATRC Atricure, Inc. | ▲ | $2.85B |
| UFPT Ufp Technologies Inc | ▶ | $2.26B |
| INSP Inspire Medical Systems, Inc. | ▲ | $1.99B |
| LMAT Lemaitre Vascular Inc | ▶ | $1.85B |
| NVCR Novocure Ltd | ▲ | $1.64B |
| KMTS Kestra Medical Technologies, Ltd. | ▲ | $1.62B |
| ATEC Alphatec Holdings, Inc. | ▲ | $1.62B |
| TNDM Tandem Diabetes Care Inc | ▲ | $1.13B |
| IRMD Iradimed Corp | ▶ | $1.13B |
| DRTS Alpha Tau Medical Ltd. | ▲ | $1.08B |
| AORT Artivion, Inc. | ▼ | $1.06B |
| IART Integra Lifesciences Holdings Corp | ▲ | $1.03B |
| PRCT Procept Biorobotics Corp | ▲ | $1.01B |
| BVS Bioventus Inc. | ▶ | $908M |
| SIBN Si-Bone, Inc. | ▼ | $882M |
| BBNX Beta Bionics, Inc. | ▲ | $863M |
| SGP Spyglass Pharma, Inc. | ▲ | $803M |
| MDXG Mimedx Group, Inc. | ▶ | $646M |
| KIDS Orthopediatrics Corp | ▶ | $573M |
| TCMD Tactile Systems Technology Inc | ▼ | $510M |
| SSII Ss Innovations International, Inc. | ▶ | $507M |
| DCTH Delcath Systems, Inc. | ▲ | $497M |
| ANGO Angiodynamics Inc | ▲ | $473M |
| SGHT Sight Sciences, Inc. | ▲ | $456M |
| BWAY Brainsway Ltd. | ▲ | $448M |
| CERS Cerus Corp | ▲ | $439M |
| NPCE Neuropace Inc | ▲ | $420M |
| RCEL Avita Medical, Inc. | ▲ | $403M |
| OFIX Orthofix Medical Inc. | ▼ | $382M |
| CARL Carlsmed, Inc. | ▲ | $366M |
| EMBC Embecta Corp. | ▶ | $355M |
| OBIO Orchestra Biomed Holdings, Inc. | ▲ | $328M |
| CLPT Clearpoint Neuro, Inc. | ▲ | $277M |
| MOBI Mobia Medical, Inc. | ▼ | $269M |
| ANIK Anika Therapeutics, Inc. | ▼ | $267M |
| TMCI Treace Medical Concepts, Inc. | ▲ | $252M |
| OSUR Orasure Technologies Inc | ▲ | $249M |
Where MDLN sits on the market map
Industrial Applications and Services · Surgical & Medical Instruments & Apparatus
News
Medline Inc. (MDLN) stock news
Medline Inc Ordinary Shares - Class A
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. With over $28 billion in revenue during 2025, Medline distributes more than 335,000 stock-keeping ...
MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ: MDLN) for potential ...
FAQ
Medline Inc. (MDLN) stock forecast FAQ
What is the Medline Inc. (MDLN) stock forecast?
On Oct. 16, 2026, MDLN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5184 stocks scored that day.
How accurate are Medline Inc. stock predictions?
For MDLN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 103 forecast dates between 2026-02-25 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 31.0%, measured on 146 forecast dates between 2026-02-25 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Medline Inc. forecasts updated?
Medline Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Medline Inc.'s industry peers?
60 issuers in our coverage, MDLN included, share the SEC industry code Surgical & Medical Instruments & Apparatus. The largest are: Stryker Corp (SYK), 3m Co (MMM), Boston Scientific Corp (BSX), Becton Dickinson & Co (BDX), Resmed Inc (RMD), Dexcom Inc (DXCM).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.